Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy.

about

Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy.

Item

http://www.wikidata.org/entity/Q54940587

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Efficacy and Safety of Rituxim ...... sitive Membranous Nephropathy.

@en

Efficacy and Safety of Rituxim ...... sitive Membranous Nephropathy.

@nl

type

Item

label

Efficacy and Safety of Rituxim ...... sitive Membranous Nephropathy.

@en

Efficacy and Safety of Rituxim ...... sitive Membranous Nephropathy.

@nl

prefLabel

Efficacy and Safety of Rituxim ...... sitive Membranous Nephropathy.

@en

Efficacy and Safety of Rituxim ...... sitive Membranous Nephropathy.

@nl

P1476

Efficacy and Safety of Rituxim ...... sitive Membranous Nephropathy.

@en

P2093

Fabrice Mihout

http://www.w3.org/2001/XMLSchema#string

Gilbert Zanetta

http://www.w3.org/2001/XMLSchema#string

Hanna Debiec

http://www.w3.org/2001/XMLSchema#string

Isabelle Brochériou

http://www.w3.org/2001/XMLSchema#string

Julie Peltier

http://www.w3.org/2001/XMLSchema#string

Karine Dahan

http://www.w3.org/2001/XMLSchema#string

Pierre Ronco

http://www.w3.org/2001/XMLSchema#string

P2860

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

The Role of cccDNA in HBV Maintenance.

Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?

Membranous nephropathy related to hepatitis B virus in adults.

Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.

Hepatitis B virus-associated nephropathy.

A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy

Viral nephropathy.

Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations.

P304

486-491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1016/J.EKIR.2017.09.009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Guerrot

Lena Berchtold

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29725654

http://www.w3.org/2001/XMLSchema#string

P932

5932116

http://www.w3.org/2001/XMLSchema#string